Perdaman Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2008.
2008 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Perdaman Pharmaceuticals Private Limited

Perdaman Pharmaceuticals Private Limited, a active private limited company, was established on 04 March 2008 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233DL2008PTC174864. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹12.03 Cr.

Formerly known as Perdaman Financial Services And Holdings Private Limited. It upholds a compliant status. Its leadership includes Vikas Rambal (Director), Manoj Kumar Rambal (Director), Usha Rambal (Director). Past directors included Indeevar Kaul, Vikas Rambal, Manish Kumar Gupta. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at N-9, Ground Floor Panchsheel Park, New Delhi, Delhi, 110017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233DL2008PTC174864

  • Registration Number

    174864

  • Incorporation Date

    04 March 2008

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹12.03 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 12.03 Cr
  • Company Age 18 Year, 1 Day
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 5.20%
  • Profit Growth **** 18.88%
  • Ebitda **** 32.34%
  • Net Worth 3.20%
  • Total Assets **** 30.08%
Company report

Perdaman Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Perdaman Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Perdaman Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vikas Rambal Director 01 Dec 2015 Current
Manoj Kumar Rambal Director 15 May 2010 Current
Usha Rambal Director 14 Oct 2010 Current
Samir Madhukar Garud Director 20 Jun 2013 Current
Sarojni Rambal Director 24 Jan 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jan 2017 Past
Pramod Abcsdd Director 15 Oct 2010 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 15 Oct 2010 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Perdaman Pharmaceuticals.

Perdaman Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.2% increase. The company also saw a substantial improvement in profitability, with a 18.88% increase in profit. The company's net worth moved up by a moderate rise of 3.2%.

Perdaman Pharmaceuticals revenue growth over time
Perdaman Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 5.20%
*******
*******
*******
*******
Revenue from Operations
*******
 5.33%
*******
*******
*******
*******
Total Assets
*******
 30.08%
*******
*******
*******
*******
Profit or Loss
*******
 18.88%
*******
*******
*******
*******
Net Worth
*******
 3.20%
*******
*******
*******
*******
EBITDA
*******
 32.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Perdaman Pharmaceuticals?

In 2023, Perdaman Pharmaceuticals had a public holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Perdaman Pharmaceuticals?

Unlock and access historical data on people associated with Perdaman Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Perdaman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perdaman Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Perdaman Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Perdaman Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Progress on Dhruv Garg was appointed as a Company Secretary was appointed as a Company Secretary on 25 Mar 2025 & has been associated with this company since 11 months 11 days . was documented.

  • Balance Sheet

    The activity Perdaman Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Director Appointment

    Shubham Kumar Namdev was appointed as a Company Secretary was appointed as a Company Secretary on 20 Dec 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Sarojni Rambal was appointed as a Director was appointed as a Director on 24 Jan 2017 & has been associated with this company since 9 years 1 month . was completed.

  • Director Appointment

    Progress on Vikas Rambal was appointed as a Director was appointed as a Director on 01 Dec 2015 & has been associated with this company since 10 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Perdaman Pharmaceuticals Private Limited?

The CIN of Perdaman Pharmaceuticals Private Limited is U24233DL2008PTC174864.

Where is Perdaman Pharmaceuticals Private Limited headquartered?

Perdaman Pharmaceuticals Private Limited is headquartered at N-9, Ground Floor Panchsheel Park, New Delhi, Delhi, 110017.

When was Perdaman Pharmaceuticals Private Limited incorporated?

Perdaman Pharmaceuticals Private Limited was incorporated on 04 March 2008.

Who are the current directors of Perdaman Pharmaceuticals Private Limited?

The current directors of Perdaman Pharmaceuticals Private Limited are

What is the primary industry of Perdaman Pharmaceuticals Private Limited?

The primary industry of Perdaman Pharmaceuticals Private Limited is Trade.

Is Perdaman Pharmaceuticals Private Limited a listed company?

Perdaman Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Perdaman Pharmaceuticals Private Limited?

The authorized capital of Perdaman Pharmaceuticals Private Limited is ₹15.00 Cr, and the paid-up capital is ₹12.03 Cr.

What is the compliance status of Perdaman Pharmaceuticals Private Limited?

The compliance status of Perdaman Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available